mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
7e-20 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-18 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-18 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
8e-17 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
8e-16 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-15 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-14 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-14 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-14 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-14 |